Intellectual Property
Apr. 16, 2014
Irvine heart valve company obtains rare injunction
Edwards Lifesciences Corp. obtained a preliminary sales ban against a line of artificial heart valves produced by Minnesota-based rival Medtronic Inc.
Daily Journal Staff Writer
Irvine-based Edwards Lifesciences Corp. has won a preliminary sales ban against a line of artificial heart valves produced by Minnesota-based rival Medtronic Inc.
The timing of the injunction is especially important, as Medtronic had just obtained regulatory approval from the U.S. Food and Drug Administration to sell its CoreValve Generation 3 devices earlier this year. Edwards Lifesciences AG v. Core...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In